Novartis · Gene Therapy · Phase 1/2
CompletedTherapeutic
Population
Adults · 18–75 years
Non-genetic severe-to-profound hearing loss
Evidence
trial
Confidence
89%
Indications
Hearing LossSensorineural Hearing Loss
Therapies database
Find a therapy. Follow the evidence.
See what is being studies, who is developing it, and how far it has progressed.
Search therapy records
Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.
More filters and sort (2 active)
1 result
A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.
How records are checked